{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:02:58Z","timestamp":1762506178138},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T00:00:00Z","timestamp":1379894400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2253-13-24","type":"journal-article","created":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T07:02:23Z","timestamp":1379919743000},"source":"Crossref","is-referenced-by-count":19,"title":["Evaluation of suspected malignant hyperthermia events during anesthesia"],"prefix":"10.1186","volume":"13","author":[{"given":"Frank","family":"Schuster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Johannsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Schneiderbanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Roewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,23]]},"reference":[{"key":"172_CR1","first-page":"142","volume":"31","author":"O Bandschapp","year":"2012","unstructured":"Bandschapp O, Girard T: Malignant hyperthermia. Swiss Med Wkly. 2012, 31: 142-","journal-title":"Swiss Med Wkly"},{"key":"172_CR2","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/00000542-200211000-00007","volume":"97","author":"N Monnier","year":"2002","unstructured":"Monnier N, Krivosic-Horber R, Payen JF, Kozak-Ribbens G, Nivoche Y, Adnet P, Reyford H, Lunardi J: Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility. Anesthesiology. 2002, 97: 1067-1074. 10.1097\/00000542-200211000-00007.","journal-title":"Anesthesiology"},{"key":"172_CR3","first-page":"26","volume-title":"Malignant hyperthermia","author":"H Ording","year":"2000","unstructured":"Ording H: Epidemiology of malignant hyperthermia. Malignant hyperthermia. Edited by: Schulte Am Esch J, Scholz J, Wappler F. 2000, Lengerich: Pabst Science Publishers, 26-29."},{"key":"172_CR4","first-page":"61","volume":"11","author":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte","year":"2001","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte: Bekanntmachung der Erl\u00f6schung fiktiver Arzneimittelzulassungen nach $ 105 Abs. 3 Satz 1 des Arzneimittelgesetzes. Bundesanzeiger. 2001, 11: 61-62.","journal-title":"Bundesanzeiger"},{"key":"172_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/bja\/aer132","volume":"107","author":"PM Hopkins","year":"2011","unstructured":"Hopkins PM: Malignant hyperthermia: pharmacology of triggering. Br J Anaesth. 2011, 107: 48-56. 10.1093\/bja\/aer132.","journal-title":"Br J Anaesth"},{"key":"172_CR6","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1097\/00000542-199306000-00018","volume":"78","author":"DJ Wedel","year":"1993","unstructured":"Wedel DJ, Gammel SA, Milde JH, Iaizzo PA: Delayed onset of malignant hyperthermia induced by isoflurane and desflurane compared with halothane in susceptible swine. Anesthesiology. 1993, 78: 1138-1144. 10.1097\/00000542-199306000-00018.","journal-title":"Anesthesiology"},{"key":"172_CR7","first-page":"831","volume":"43","author":"DGAI info","year":"2008","unstructured":"DGAI info: Aktualisierte Stellungsnahme der DGAI. Verwendung von Succinylcholin. An\u00e4sth Intensivmed. 2008, 43: 831-","journal-title":"An\u00e4sth Intensivmed"},{"key":"172_CR8","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/bja\/56.11.1267","volume":"56","author":"The European Malignant Hyperpyrexia Group","year":"1984","unstructured":"The European Malignant Hyperpyrexia Group: A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. Br J Anaesth. 1984, 56: 1267-1269.","journal-title":"Br J Anaesth"},{"key":"172_CR9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","volume":"80","author":"MG Larach","year":"1994","unstructured":"Larach MG, Localio AR, Allen GC, Denborough MA, Ellis FR, Gronert GA, Kaplan RF, Muldoon SM, Nelson TE, Ording H: A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology. 1994, 80: 771-779. 10.1097\/00000542-199404000-00008.","journal-title":"Anesthesiology"},{"key":"172_CR10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/bja\/34.6.395","volume":"34","author":"MA Denborough","year":"1962","unstructured":"Denborough MA, Forster JF, Lovell RR, Maplestone PA, Villiers JD: Anaesthetic deaths in a family. Br J Anaesth. 1962, 34: 395-396. 10.1093\/bja\/34.6.395.","journal-title":"Br J Anaesth"},{"key":"172_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/bja\/58.4.447","volume":"58","author":"GJ Galloway","year":"1986","unstructured":"Galloway GJ, Denborough MA: Suxamethonium chloride and malignant hyperpyrexia. Br J Anaesth. 1986, 58: 447-450. 10.1093\/bja\/58.4.447.","journal-title":"Br J Anaesth"},{"key":"172_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1213\/00000539-199407000-00027","volume":"79","author":"PA Iaizzo","year":"1994","unstructured":"Iaizzo PA, Wedel DJ: Response to succinylcholine in porcine malignant hyperthermia. Anesth Analg. 1994, 79: 143-151.","journal-title":"Anesth Analg"},{"key":"172_CR13","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1213\/00000539-197311000-00010","volume":"52","author":"TE Nelson","year":"1973","unstructured":"Nelson TE, Jones EW, Bedell DM: Porcine malignant hyperthermia: a study on the triggering effects of succinylcholine. Anesth Analg. 1973, 52: 908-911.","journal-title":"Anesth Analg"},{"key":"172_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","volume":"110","author":"MG Larach","year":"2010","unstructured":"Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB: Clinical presentation, treatment, and complications of malignant hyperthermia in north America from 1987 to 2006. Anesth Analg. 2010, 110: 498-507. 10.1213\/ANE.0b013e3181c6b9b2.","journal-title":"Anesth Analg"},{"key":"172_CR15","first-page":"27","volume-title":"Presented as an abstract at the 31th Annual Meeting of the European Malignant Hyperthermia Group, Volume 31","author":"S Heiderich","year":"2012","unstructured":"Heiderich S: Multicentric clinical and genetic evaluation classifies succinylcholine as accelerant of confirmed malignant hyperthermia crises. Presented as an abstract at the 31th Annual Meeting of the European Malignant Hyperthermia Group, Volume 31. 2012, Leeds, Great Britain, 27-"},{"key":"172_CR16","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/00000542-199406000-00009","volume":"80","author":"RP O\u2019Flynn","year":"1994","unstructured":"O\u2019Flynn RP, Shutack JG, Rosenberg H, Fletcher JE: Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis. Anesthesiology. 1994, 80: 1228-1233. 10.1097\/00000542-199406000-00009.","journal-title":"Anesthesiology"},{"key":"172_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1055\/s-2007-994266","volume":"33","author":"F Wappler","year":"1998","unstructured":"Wappler F, Scholz J, von Richthofen V, Fiege M, K\u00f6chling A, Matschke J, Winkler G, Schulte am Esch J: Incidence of disposition for malignant hyperthermia in patients with neuromuscular diseases. Anasthesiol Intensivmed Notfallmed Schmerzther. 1998, 33: 373-380. 10.1055\/s-2007-994266.","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"172_CR18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0310057X0203000410","volume":"30","author":"AN Pollock","year":"2002","unstructured":"Pollock AN, Langton EE, Couchman K, Stowell KM, Waddington M: Suspected malignant hyperthermia reactions in New Zealand. Anaesth Intensive Care. 2002, 30: 453-461.","journal-title":"Anaesth Intensive Care"},{"key":"172_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta14390","volume":"14","author":"D Chambers","year":"2010","unstructured":"Chambers D, Paulden M, Paton F, Heirs M, Duffy S, Craig D, Hunter J, Wilson J, Sculpher M, Woolacott N: Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment. Health Technol Assess. 2010, 14: 1-211.","journal-title":"Health Technol Assess"},{"key":"172_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1399-6576.2011.02573.x","volume":"56","author":"T Migita","year":"2012","unstructured":"Migita T, Mukaida K, Kobayashi M, Hamada H, Kawamoto M: The severity of sevoflurane-induced malignant hyperthermia. Acta Anaesthesiol Scand. 2012, 56: 351-356. 10.1111\/j.1399-6576.2011.02573.x.","journal-title":"Acta Anaesthesiol Scand"},{"key":"172_CR21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1213\/00000539-200301000-00034","volume":"96","author":"CW Hoenemann","year":"2003","unstructured":"Hoenemann CW, Halene-Holtgraeve TB, Booke M, Hinder F, Daudel F, Reich A, Van Aken H: Delayed onset of malignant hyperthermia in desflurane anesthesia. Anesth Analg. 2003, 96: 165-167.","journal-title":"Anesth Analg"},{"key":"172_CR22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1213\/01.ane.0000189553.57833.11","volume":"102","author":"F Schuster","year":"2006","unstructured":"Schuster F, Sch\u00f6ll H, Hager M, M\u00fcller R, Roewer N, Anetseder M: The dose\u2013response relationship and regional distribution of lactate after intramuscular injection of halothane and caffeine in malignant hyperthermia-susceptible pigs. Anesth Analg. 2006, 102: 468-472. 10.1213\/01.ane.0000189553.57833.11.","journal-title":"Anesth Analg"},{"key":"172_CR23","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/01.anes.0000281915.85577.1a","volume":"107","author":"F Schuster","year":"2007","unstructured":"Schuster F, Metterlein T, Negele S, Gardill A, Schwemmer U, Roewer N, Anetseder M: Intramuscular injection of sevoflurane detects malignant hyperthermia predisposition in susceptible pigs. Anesthesiology. 2007, 107: 616-620. 10.1097\/01.anes.0000281915.85577.1a.","journal-title":"Anesthesiology"},{"key":"172_CR24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/EJA.0b013e32833ed06c","volume":"28","author":"T Metterlein","year":"2011","unstructured":"Metterlein T, Schuster F, Kranke P, Roewer N, Anetseder M: In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?. Eur J Anaesthesiol. 2011, 28: 251-255.","journal-title":"Eur J Anaesthesiol"},{"key":"172_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00000542-199907000-00026","volume":"91","author":"G Kunst","year":"1999","unstructured":"Kunst G, Graf BM, Schreiner R, Martin E, Fink RH: Differential effects of sevoflurane, isoflurane, and halothane on Ca2+ release from the sarcoplasmic reticulum of skeletal muscle. Anesthesiology. 1999, 91: 179-186. 10.1097\/00000542-199907000-00026.","journal-title":"Anesthesiology"},{"key":"172_CR26","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1097\/00000542-200009000-00034","volume":"93","author":"G Kunst","year":"2000","unstructured":"Kunst G, Stucke AG, Graf BM, Martin E, Fink RH: Desflurane induces only minor Ca2+ release from the sarcoplasmic reticulum of mammalian skeletal muscle. Anesthesiology. 2000, 93: 832-836. 10.1097\/00000542-200009000-00034.","journal-title":"Anesthesiology"},{"issue":"2","key":"172_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1750-1172-2-21","volume":"24","author":"H Rosenberg","year":"2007","unstructured":"Rosenberg H, Davis M, James D, Pollock N, Stowell K: Malignant hyperthermia. Orphanet J Rare Dis. 2007, 24 (2): 21-","journal-title":"Orphanet J Rare Dis"},{"key":"172_CR28","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1055\/s-0029-1242125","volume":"44","author":"F Schuster","year":"2009","unstructured":"Schuster F, M\u00fcller-Reible CR: Malignant hyperthermia\u2013diagnostics, treatment and anaesthetic management. Anasthesiol Intensivmed Notfallmed Schmerzther. 2009, 44: 758-763. 10.1055\/s-0029-1242125.","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"172_CR29","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/humu.20356","volume":"27","author":"R Robinson","year":"2006","unstructured":"Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P: Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat. 2006, 27: 977-989. 10.1002\/humu.20356.","journal-title":"Hum Mutat"},{"key":"172_CR30","first-page":"1572","volume":"A","author":"JH Kim","year":"2011","unstructured":"Kim JH, Jarvik GP, Browning BL, Halsall J, Hopkins PM: Exome sequencing and identity by descent (IBD) analysis in malignant hyperthermia gene discovery. Anesthesiology. 2011, A: 1572-","journal-title":"Anesthesiology"},{"key":"172_CR31","volume-title":"Causative RyR1 mutations","author":"European Malignant Hyperthermia Group","year":"2013","unstructured":"European Malignant Hyperthermia Group: Causative RyR1 mutations. 2013, http:\/\/www.emhg.org\/genetics\/mutations-in-ryr1\/ ,"},{"key":"172_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/bja\/86.2.283","volume":"86","author":"A Urwyler","year":"2001","unstructured":"Urwyler A, Deufel T, McCarthy T, West S, European Malignant Hyperthermia Group: Guidelines for molecular Genetic detection of susceptibility to malignant hyperthermia. Br J Anaesth. 2001, 86: 283-287. 10.1093\/bja\/86.2.283.","journal-title":"Br J Anaesth"},{"key":"172_CR33","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00101-003-0461-7","volume":"52","author":"MU Gerbershagen","year":"2003","unstructured":"Gerbershagen MU, Fiege M, Krause T, Agarwal K, Wappler F: Dantrolene. Pharmacological and therapeutic aspects. Anaesthesist. 2003, 52: 238-245. 10.1007\/s00101-003-0461-7.","journal-title":"Anaesthesist"},{"key":"172_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/bja\/aeq243","volume":"105","author":"KP Glahn","year":"2010","unstructured":"Glahn KP, Ellis FR, Halsall PJ, M\u00fcller CR, Snoeck MM, Urwyler A, Wappler F, European Malignant Hyperthermia Group: Recognizing and managing a malignant hyperthermia crisis: guidelines from the European malignant hyperthermia group. Br J Anaesth. 2010, 105: 417-420. 10.1093\/bja\/aeq243.","journal-title":"Br J Anaesth"},{"key":"172_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1055\/s-0033-1342900","volume":"48","author":"F Schuster","year":"2013","unstructured":"Schuster F, Johannsen S, Roewer N: Deklaration von Helsinki zur Patientensicherheit in der An\u00e4sthesiologie: SOP zur Malignen Hyperthermie. Anasthesiol Intensivmed Notfallmed Schmerzther. 2013, 48: 162-164.","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"172_CR36","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/01.anes.0000265148.86566.68","volume":"106","author":"JM Burkman","year":"2007","unstructured":"Burkman JM, Posner KL, Domino KB: Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reactions. Anesthesiology. 2007, 106: 901-906. 10.1097\/01.anes.0000265148.86566.68.","journal-title":"Anesthesiology"},{"key":"172_CR37","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1055\/s-2007-994239","volume":"33","author":"V von Richthofen","year":"1998","unstructured":"von Richthofen V, Wappler F, Scholz J, Fiege M, Schulte Am Esch J: Evaluation of malignant hyperthermia episodes with the clinical grading scale. Anasthesiol Intensivmed Notfallmed Schmerzther. 1998, 33: 244-249. 10.1055\/s-2007-994239.","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2253-13-24\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2253-13-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2253-13-24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2253-13-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T16:46:22Z","timestamp":1646585182000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/1471-2253-13-24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,23]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["172"],"URL":"https:\/\/doi.org\/10.1186\/1471-2253-13-24","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,23]]},"article-number":"24"}}